NP+PA Perspectives in Dermatology

EXCLUSIVE AUDIO SERIES: Atopic Dermatitis Advisor

After reviewing notable safety considerations for systemic and topical Janus kinase inhibitors for patients with atopic dermatitis, Nicole Keeter, PA-C, describes steps she has taken to become more comfortable prescribing these agents to her patients with AD and discusses important tips for counseling these patients on adverse events and black box warnings.

Current issue

NP+PA Perspectives in Dermatology: March 2023

The Psoriasis Decision Tree

Anthralin’s Applicability in the Treatment of Pediatric Alopecia Areata

Lymphatic Vessel Morphometry: Is It a Predictor for Aggressive Basal Cell Carcinoma?

Special Bonus Issue—Dermatology NP & PA Workforce Survey: Practice Characteristics and Compensation

Dermatological Conditions in Skin of Color— Physiological Nuances in Skin of Color and Their Clinical Implications

Incorporating JAK Inhibitors into Clinical Practice for the Treatment of Atopic Dermatitis—Safety Considerations